Skip Nav Destination
Issues
Treatment resistant mood disorders, Vol. 4, Iss. 5
-
Cover Image
Cover Image
![issue cover]()
Consumer perception, knowledge, and uses of cannabidiol
Cambrey Nguyen, PharmD, Karen E. Moeller, PharmD, Michael McGuire, PharmD, Brittany L. Melton, PharmD, PhD
Predictors of persistence and adherence to deutetrabenazine among patients with Huntington disease or tardive dyskinesia
Daniel O. Claassen, MD, Rajeev Ayyagari, PhD, Viviana García-Horton, PhD, Su Zhang, PhD, Sam Leo, PharmD
Exploring real-world symptom impact and improvement in well-being domains for tardive dyskinesia in VMAT2 inhibitor-treated patients via clinician survey and chart review
Jonathan M. Meyer, MD, Craig Chepke, MD, Rimal B. Bera, MD, M. Mercedes Pérez-Rodríguez, MD, PhD, Leslie Lundt, MD, Ericha G. Franey, PhD, Rahul Dhanda, PhD, MA, Betsy Benning, MBA, Morgan Bron, PharmD, MS, Chuck Yonan, PharmD
Impact of Board Certified Psychiatric Pharmacists on improving urinary tract infection antibiotic appropriateness at an acute psychiatric hospital
Mohammad Adam Hamad, PharmD, BCPS, Andrew Williams, PharmD, BCPP, Jamie Kneebusch, PharmD, BCPS, BCPP, Niyati Butala, PharmD, BCPP
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports
Alejandro Del Rio Verduzco, PharmD, MS, Ahva Salari, BS, Parna Haghparast, PharmD, BCPS